You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The new consortium is aiming to make comprehensive genomic profiling accessible to advanced cancer patients in the US, to help inform their treatment decisions.
Carebox's system matches eligibility criteria from clinical trial databases with patients' health and genomic data to identify potentially relevant studies.
The deal enables Genosity to add Olink's proteomics technology with next-generation sequencing readout to its repertoire of services.
Using Revel Health's health action platform, the partners will communicate and promote CLS's genetic testing offering to Medicare Advantage members.
The Carlsbad, California-based company said that the contract — its third with the EPA — has a potential value of $25 million over five years.
The deal includes integrating an online ordering process for Ambry's genetic tests into Volpara's Aspen Breast software for medical practice management.
The companies will bundle claims analytics, clinical decision support, provider education, and other pharmacist-driven support for prescribers.
The companies have agreed to combine their respective offerings into a single services package for drug target identification and validation.
Saga has developed a digital PCR-based technology that it says can detect circulating tumor DNA with a mutational allele frequency of 0.001 percent.
Illumina, Twist Bioscience, and DNA Script are among the private sector collaborators of the groups receiving funds to develop technology platforms.
Reuters reports that Germany is seeking to sequence 5 percent of patient samples that test positive for SARS-CoV-2.
23andMe and Medscape say primary care physicians are increasingly more comfortable with discussing direct-to-consumer genetic testing results.
The publisher of the Science family of journals will allow some authors to place peer-reviewed versions of their papers into publicly accessible repositories.
In Science this week: analysis of genome-wide association studies of chronic kidney disease, and more.